- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04988139
Effects of Educational Training on Children With Developmental Delay
Therapeutic Effects of Individualized Educational Training on Preschool Children With Global Developmental Delay
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A total of 20 preschool children with developmental delay who are receiving traditional rehabilitation programs will be enrolled.
The participants will be randomized into two groups, including the intervention group (traditional rehabilitation program with individualized educational training: one time per week, 50 min per session, with a total of 4 sessions in one month) and the control group (traditional rehabilitation program without individualized educational training).
Therapeutic effects, including pediatric daily activity, attention, cognitive function, functional performance, quality of life, and physical functional performance at baseline, after one month of treatment, and 3 months after the treatment, will be evaluated.
The evaluators will be blinded to the group's allocation during the whole course of the intervention.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ru-Lan Hsieh, MD
- Phone Number: 2531 886228332211
- Email: M001052@ms.skh.org.tw
Study Contact Backup
- Name: Ru-Lan Hsieh, MD
- Phone Number: 2531 886228332211
- Email: rulan1052@tmu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 111-01
- Shin Kong Wu Ho-Su Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- preschool children with a diagnosis of developmental delay, under regular traditional rehabilitation programs, intelligence quotient 70 or greater
Exclusion Criteria:
- age less than 3 or greater than 6 of children diagnosed with developmental delay, under regular traditional rehabilitation programs, intelligence quotient 70 or greater
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intervention group
traditional rehabilitation programs with additional individualized educational training
|
50 min per session, one session per week, 4 sessions per month, of individualized educational training to preschool children with developmental delays under traditional rehabilitation programs
|
|
No Intervention: Control group
traditional rehabilitation programs without additional individualized educational training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes of daily activity
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Pediatric Daily Occupation Scale
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of attention
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Conners Kiddie Continous Performance Test, 2nd edition
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change of visual motor integration
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Beery-Buktenica Visual Motor Integration
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
change of intelligence
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Wechsler Intelligence Scale of children
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
Changes of functional performance
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Pediatric Outcome Data Collection Instrument
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of quality of life
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Pediatric Quality of Life Inventory
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of family impact
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
score assessed by Child Health Questionnaire, parent form 28
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of walking speed
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
walking speed
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of chair climbing speed
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
stairs climbing speed
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of balance
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
one leg standing time
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of balance and coordination
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
timed up and go test
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
|
changes of physical function
Time Frame: score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
5 times sit to stand test
|
score change from baseline to 1 month of treatment, and 3 months after treatment, lower scores mean a worse outcome
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021SKHADR032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.